Approval · Notice of Compliance 8265 · 2006
TYGACIL: Notice of Compliance 8265
Issued September 14, 2006
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8265
- Date
- September 14, 2006
- Company
- Wyeth CanadaSt. Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Tetracycline antibiotic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TYGACIL | 02285401 | Marketed |
Medicinal ingredients
- TIGECYCLINE 50 MG per VIAL